Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer

por Yuan, Kaiyu, Yong, Sun, Xu, Fei, Zhou, Tong, McDonald, Jay M, Chen, Yabing
Publicado 2015

Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation

por Yang, Shan-zhong, Xu, Fei, Yuan, Kaiyu, Sun, Yong, Zhou, Tong, Zhao, Xinyang, McDonald, Jay M, Chen, Yabing
Publicado 2020

Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin

por Wang, Qiang, Xie, Yi, Du, Quan-Sheng, Wu, Xiao-Jun, Feng, Xu, Mei, Lin, McDonald, Jay M., Xiong, Wen-Cheng
Publicado 2003

Characterization of Calmodulin–Fas Death Domain Interaction: An Integrated Experimental and Computational Study

por Fancy, Romone M., Wang, Lingyun, Napier, Tiara, Lin, Jiabei, Jing, Gu, Lucius, Aaron L., McDonald, Jay M., Zhou, Tong, Song, Yuhua
Publicado 2014

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib

por Bi, Lilia L, Pan, George, Atkinson, T Prescott, Zheng, Lixin, Dale, Janet K, Makris, Christopher, Reddy, Vishnu, McDonald, Jay M, Siegel, Richard M, Puck, Jennifer M, Lenardo, Michael J, Straus, Stephen E
Publicado 2007